Release Notes:
Data Element
Version 2018B
| Data Element Name: |
IA Route of Alteplase Administration |
|---|
| Collected For: |
CSTK-05, CSTK-07, CSTK-08, CSTK-09 |
|---|
| Definition: | The route of alteplase administration was intra-arterial (IA). Alteplase may be administered intra-venously (IV) by infusion directly into a vein through a peripheral or central venous catheter, or it may be given through an endovascular mircrocatheter delivery system positioned in an artery to directly infuse alteplase into the clot.
|
|---|
| Suggested Data Collection Question: | Is there documentation that the route of alteplase administration was intra-arterial (IA)? |
|---|
| Format: |
| Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) The route of alteplase administration was intra-arterial (IA).
N (No) The route of alteplase administration was not intra-arterial (IA), OR unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- If the route of alteplase administration is documented as intra-arterial (IA), select “Yes”.
- If both intravenous (IV) and intra-arterial (IA) alteplase are given either in different procedures or the same procedure, select “Yes”.
Examples:
- “IV alteplase given at hospital ‘A’ prior to transfer to hospital ‘B’ (i.e. drip and ship). Mechanical thrombectomy with IA alteplase was performed at hospital ‘B’”.
- “NIHSS score 3 on arrival to this hospital. IV alteplase initiated in ED with initial improvement noted and NIHSS score zero post-infusion. NIHSS score 5 one hour later. Patient taken to interventional suite and IA alteplase administered.”
- If the only route of alteplase administration was intra-venous (IV) at this hospital or a transferring hospital, select “No”.
- If IA alteplase was administered at another hospital and the patient subsequently transferred to this hospital, select “No”.
|
|---|
| Suggested Data Sources: |
- Consultation notes
- Diagnostic test reports
- Operative notes
- Procedure notes
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion |
Exclusion |
Only Acceptable Thrombolytic Therapy for Stroke:
- Activase
- Alteplase
- IA t-PA
- Recombinant Tissue Plasminogen Activator(rt-PA)
- Tissue Plasminogen Activator(t-PA)
|
- Intravenous (IV) alteplase (t-PA)
- IA administration of thrombolytic agents not listed as inclusions
|
|
IA Route of Alteplase Administration
Specifications Manual for Joint Commission National Quality Measures (v2018B)
Discharges 01-01-19 (1Q19) through 06-30-19 (2Q19)
^